|
SS18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13289999995148E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.65980000000188E-05 |
| Normal-vs-Stage2 |
6.30029999948434E-07 |
| Normal-vs-Stage3 |
1.62028999999286E-05 |
| Normal-vs-Stage4 |
3.90189999976975E-07 |
| Stage1-vs-Stage2 |
7.795700E-02 |
| Stage1-vs-Stage3 |
5.534200E-02 |
| Stage1-vs-Stage4 |
6.224100E-02 |
| Stage2-vs-Stage3 |
4.578600E-01 |
| Stage2-vs-Stage4 |
1.031960E-01 |
| Stage3-vs-Stage4 |
5.112600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44720000042165E-07 |
| Normal-vs-AfricanAmerican |
2.577500E-04 |
| Normal-vs-Asian |
1.5125099999902E-05 |
| Caucasian-vs-AfricanAmerican |
5.080400E-01 |
| Caucasian-vs-Asian |
1.571180E-01 |
| AfricanAmerican-vs-Asian |
6.968200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08240000296078E-08 |
| Normal-vs-Female |
2.608500E-02 |
| Male-vs-Female |
1.989540E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.900960E-03 |
| Normal-vs-Extreme_Weight |
4.40390000000512E-06 |
| Normal-vs-Obese |
1.80406999999994E-05 |
| Normal-vs-Extreme_Obese |
4.435900E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.374000E-01 |
| Normal_Weight-vs-Obese |
7.647600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.120400E-01 |
| Extreme_Weight-vs-Obese |
8.229200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.987600E-01 |
| Obese-vs-Extreme_Obese |
6.670800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.120820E-03 |
| Normal-vs-Age(41-60Yrs) |
3.377900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.47849999915439E-08 |
| Normal-vs-Age(81-100Yrs) |
3.139800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.558000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.648400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.514400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.889800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.995230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.107400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.35600000000536E-05 |
| Normal-VS-Type2 PRCC |
9.86119963464205E-10 |
| Normal-VS-KIRP CIMP |
1.174520E-04 |
| Normal-VS-Unclassified PRCC |
4.174100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.903590E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.188210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.150600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.631000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.048200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.140000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53839999961214E-07 |
| Normal-vs-N1 |
4.87920004399456E-09 |
| Normal-vs-N2 |
2.879100E-03 |
| N0-vs-N1 |
3.981000E-01 |
| N0-vs-N2 |
7.190800E-01 |
| N1-vs-N2 |
9.401600E-01 |
|
|
